Mendonsa et al. suggested that leptin, after binding to its receptors present on pancreatic cancer cell lines, contributes to pancreatic tumor growth through activation of the PI3K/AKT pathway [57]. The gene discussed is LEP; the disease is familial pancreatic carcinoma.